169 related articles for article (PubMed ID: 22854194)
1. Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG.
Anand N; Singh P; Sharma A; Tiwari S; Singh V; Singh DK; Srivastava KK; Singh BN; Tripathi RP
Bioorg Med Chem; 2012 Sep; 20(17):5150-63. PubMed ID: 22854194
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of some novel chalcones, flavanones and flavones and evaluation of their anti-inflammatory activity.
Bano S; Javed K; Ahmad S; Rathish IG; Singh S; Chaitanya M; Arunasree KM; Alam MS
Eur J Med Chem; 2013 Jul; 65():51-9. PubMed ID: 23693150
[TBL] [Abstract][Full Text] [Related]
3. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.
Chiaradia LD; Mascarello A; Purificação M; Vernal J; Cordeiro MN; Zenteno ME; Villarino A; Nunes RJ; Yunes RA; Terenzi H
Bioorg Med Chem Lett; 2008 Dec; 18(23):6227-30. PubMed ID: 18930396
[TBL] [Abstract][Full Text] [Related]
4. Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum.
Geist JG; Lauw S; Illarionova V; Illarionov B; Fischer M; Gräwert T; Rohdich F; Eisenreich W; Kaiser J; Groll M; Scheurer C; Wittlin S; Alonso-Gómez JL; Schweizer WB; Bacher A; Diederich F
ChemMedChem; 2010 Jul; 5(7):1092-101. PubMed ID: 20480490
[TBL] [Abstract][Full Text] [Related]
5. Rapid discovery of potent α-fucosidase inhibitors by in situ screening of a library of (pyrrolidin-2-yl)triazoles.
Elías-Rodríguez P; Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Robina I
Org Biomol Chem; 2014 Aug; 12(31):5898-904. PubMed ID: 24984102
[TBL] [Abstract][Full Text] [Related]
6. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
Duval R; Kolb S; Braud E; Genest D; Garbay C
J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
[No Abstract] [Full Text] [Related]
7. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
8. Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).
Wang H; Robl JA; Hamann LG; Simpkins L; Golla R; Li YX; Seethala R; Zvyaga T; Gordon DA; Li JJ
Bioorg Med Chem Lett; 2011 Jul; 21(14):4146-9. PubMed ID: 21689935
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Jun N; Hong G; Jun K
Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
[TBL] [Abstract][Full Text] [Related]
11. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.
Mascarello A; Chiaradia LD; Vernal J; Villarino A; Guido RV; Perizzolo P; Poirier V; Wong D; Martins PG; Nunes RJ; Yunes RA; Andricopulo AD; Av-Gay Y; Terenzi H
Bioorg Med Chem; 2010 Jun; 18(11):3783-9. PubMed ID: 20462762
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II.
Khera MK; Cliffe IA; Prakash O
Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-cancer activity evaluation of new dimethoxylated chalcone and flavanone analogs.
Ketabforoosh SH; Kheirollahi A; Safavi M; Esmati N; Ardestani SK; Emami S; Firoozpour L; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2014 Nov; 347(11):853-60. PubMed ID: 25201534
[TBL] [Abstract][Full Text] [Related]
17. IRAK-4 inhibitors. Part 1: a series of amides.
Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure elucidation of five new conjugates of oleanolic acid derivatives and chalcones using 1D and 2D NMR spectroscopy.
Tang C; Zhu L; Li J; Qin R; Liu C; Chen Y; Yang G
Magn Reson Chem; 2012 Mar; 50(3):236-41. PubMed ID: 22383429
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
[TBL] [Abstract][Full Text] [Related]
20. A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling.
Székely R; Wáczek F; Szabadkai I; Németh G; Hegymegi-Barakonyi B; Eros D; Szokol B; Pató J; Hafenbradl D; Satchell J; Saint-Joanis B; Cole ST; Orfi L; Klebl BM; Kéri G
Immunol Lett; 2008 Mar; 116(2):225-31. PubMed ID: 18258308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
